Recombinant fragment corresponding to Human Fibulin 5 aa 250 to the C-terminus (internal sequence).
This product is a recombinant monoclonal antibody, which offers several advantages including:
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies.